(855) 264-3218Clinical Trials
AnidasoHub

Clinical research study

New York, NY

Migraine · Phase 3

Elismetrep for Acute Migraine

Fieve Clinical Research
Public Disclosure
About this study

This study checks whether a new drug called elismetrep works better than placebo to stop migraine attacks as they happen. If you get regular migraines and want to help find better treatments, this may be for you. You'll track your migraines using a smartphone app and visit the clinic a few times over several weeks.

Key criteria
  • Age 18–75
  • Migraines 2–10 times per month
  • Migraine history of 1+ year
  • Willing to use smartphone app
  • Non-pregnant or using birth control

A few of the main points — Anida will check the rest with you.

Check if you may be a match

Anida asks a few questions to see whether you may be a fit — free & private. Nothing is shared with a research site unless you choose to.

Know someone who might be interested? Pass it on.